Synta Pharmaceuticals Corp (NASDAQ:SNTA)

4.05
Data as of Jul 25
 -0.04 / -0.98%
Today’s Change
3.70
Today|||52-Week Range
7.85
-22.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Caxton Corp
Director
Buy11/13/20133,400,000$3.75$12.8M+7.14%
Caxton Corp
Buy11/13/20131,600,000$3.75$6.0M+7.14%
Gollust Keith R
Director
Buy11/13/2013150,000$3.75$562.5K+7.14%
Bahcall Safi R
President & Chief Executive Officer
Buy11/13/201320,000$3.75$75.0K+7.14%
Reardon William S
Director
Buy11/13/201313,333$3.75$50.0K+7.14%
Singh Amarinder
Senior Vice President & Chief Business Officer
Sale12/02/20135,870$5.00$29.4K-19.32%
Bernitz Steven B
Senior Vice President-Corporate Development
Gift12/18/201325,000$0.00$0.00-6.68%
Wilson Robert N
Director
Gift7/01/20142,439$0.00$0.00-1.22%
Reardon William S
Director
Gift7/01/20144,878$0.00$0.00-1.22%
Gollust Keith R
Director
Gift7/01/20149,756$0.00$0.00-1.22%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.